241-255 of 831
Henry Kaminski, MD
FcRn Inhibitors: A Potential New Targeted Therapy Option
NeuroFrontiersFcRn Inhibitors: A Potential New Targeted Therapy Option
Nicholas J. Silvestri, MD
Examining Schizophrenia Risk: The Influence of B12 Levels in Early Pregnancy
NeuroFrontiersExamining Schizophrenia Risk: The Influence of B12 Levels in Early Pregnancy
Unseen Struggles: Impacts of Homelessness on Women with Schizophrenia
NeuroFrontiersUnseen Struggles: Impacts of Homelessness on Women with Schizophrenia
NKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
NeuroFrontiersNKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
NeuroFrontiersBeyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
Thomas Karikari, PhD
- advertisement
Preventing Alzheimer’s Disease Through Lifestyle Interventions
NeuroFrontiersPreventing Alzheimer’s Disease Through Lifestyle Interventions
Michele Longo, MD
Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
NeuroFrontiersAmyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
Michele Longo, MD
Transforming Schizophrenia Treatment: Advances in Medication and Therapy
NeuroFrontiersTransforming Schizophrenia Treatment: Advances in Medication and Therapy
Robert Walker, PharmD
Deanna L. Kelly, PharmD, BCPP
Advancing Schizophrenia Care: Challenges and Promising New Therapies
NeuroFrontiersAdvancing Schizophrenia Care: Challenges and Promising New Therapies
Charles Turck, PharmD, BCPS, BCCCP
Andrew J. Cutler, MD
Peter Buch, MD, FACG, AGAF, FACP
Douglas Drossman, MD
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
NeuroFrontiersDebunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
Clifford Jack Jr., MD
- advertisement
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
NeuroFrontiersReviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
Clifford Jack Jr., MD
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
NeuroFrontiersBeyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
Ashley Baker, MSN, PMHNP
Suzanne E. Schindler, MD, PhD
Diagnosing Myasthenia Gravis: The Impact of Social Media
Clinician's RoundtableDiagnosing Myasthenia Gravis: The Impact of Social Media
Ashley Baker, MSN, PMHNP
Vishnu Pandurangadu, MD/MBA, FACEP
Pritikanta Paul, MD
